Chromatin
Latest round
- Series F
Last raised
- Jan 2015
Total raised
- $71M
Investors
- 13
About Chromatin
Chromatin, Inc.Chromatin, Inc. focuses on developing agricultural solutions to improve global food security.03 mn on January 12, 2015, from Illinois Ventures and Wood Creek Capital Management.Chromatin, Inc. specializes in innovative agricultural solutions aimed at enhancing global food security amidst geopolitical challenges. The company’s core offerings include advanced breeding technologies that integrate genetic research with traditional agricultural practices, optimizing staple crops such as wheat, potatoes, corn, rye, barley, and sunflower oil.Chromatin, Inc. generates revenue through partnerships and direct sales to agricultural producers, engaging in B2B relationships that offer advanced breeding technologies and consulting services.Chromatin, Inc. The company is particularly interested in entering new geographic regions that are experiencing increased demand for food security solutions. Specific plans include targeting markets in Northern Africa and India over the next few years, focusing on the long-term sustainability of food systems.
Who invested in Chromatin
13 investors across 6 rounds
See all investors in Chromatin
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Chromatin
Who invested in Chromatin?
Chromatin has 13 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Chromatin raised?
Chromatin has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Chromatin last raise money?
Chromatin's most recent round on record is a Series F, in Jan 2015.
What does Chromatin do?
Chromatin is a biotechnology company.
Where is Chromatin headquartered?
Chromatin is headquartered in Chicago, US.
Which VCs invest in companies like Chromatin?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Chromatin's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series F
Raising like Chromatin? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.